Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial UFT/RT Randomized Multicenter Phase III Randomized Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma

NCT00207831 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT00207831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00207831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial UFT/RT Randomized Multicenter Phase III Randomized Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2004
Completion date
February 29, 2008
Enrollment
219 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

m0, n0-2, rectal cancer, stage ii/iii, t3 or t4 (only anal extension) rectal cancer